Results 41 to 50 of about 4,742 (243)

Use of Midodrine in Heart Failure: Two Case Reports and a Review of the Literature

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
Hypotension in patients with heart failure is much more frequent in daily clinical practice than the 10–15% reported in clinical trials. In patients with heart failure with reduced ejection fraction (HFrEF), hypotension frequently limits the initiation ...
Adnan Hajjiah   +6 more
doaj   +1 more source

Combination octreotide, midodrine, and albumin may improve survival in patients with Hepatorenal syndrome, but the evidence is weak [PDF]

open access: yes, 2017
A critical appraisal and clinical application of Skagen C, Einstein M, Lucey MR, Said A. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. J Clin Gastroenterol.
Szafranski, Jacob
core   +2 more sources

Formulation Development and Evaluation of Fast Dissolving Oral Film of Midodrine Hydrochloride [PDF]

open access: yes, 2020
Oral fast dissolving midodrine hydrochloride films prepared by solvent casting method, PEG 400 was the selected plasticizers, incorporating superdisintegrants such as croscarmellose sodium (CCS) and sodium starch glycolate (SSG) to achieve the goal. Drug
Ghatuary, Sailesh Kumar   +3 more
core   +2 more sources

Clinical Prognostic Factors in Pediatric Patients With Orthostatic Intolerance

open access: yesGlobal Pediatric Health, 2020
Midodrine is widely used for orthostatic intolerance (OI); however, little is known about the prognostic factors of OI after midodrine treatment. We retrospectively reviewed electronic medical charts to investigate clinical prognostic factors of OI on ...
Kazue Ishitsuka MD, MPH, PhD   +5 more
doaj   +1 more source

Midodrine treatment for chronic fatigue syndrome [PDF]

open access: yesPostgraduate Medical Journal, 2004
Abstract The long term results of midodrine treatment in a patient having debilitating chronic fatigue syndrome (CFS) are reported. Midodrine treatment, directed at the autonomic nervous system, resulted in correction of the dysautonomia followed by improvement of fatigue.
J E Naschitz   +3 more
openaire   +3 more sources

Treatment via oral midodrine in a patient with prolonged hypotension following carotid artery stenting: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Hypotension and bradycardia are common hemodynamic complications following carotid artery stenting in patients with carotid artery stenosis.
Yaser Jenab   +2 more
doaj   +1 more source

Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOrthostatic hypotension causes ≈80 000 hospitalizations per year in the United States. Treatments for orthostatic hypotension include fludrocortisone, a mineralocorticoid analog that promotes sodium reabsorption; and midodrine, an α‐1 ...
Carlos G. Grijalva   +3 more
doaj   +1 more source

Review of adjunctive midodrine to facilitate weaning intravenous vasopressors in critically ill patients [PDF]

open access: yes, 2020
Background/Purpose: Intravenous (IV) vasopressor agents are mainstay therapy for the management of refractory hypotension in critically ill patients in the intensive care unit (ICU).
Clarke, Heidi   +4 more
core   +1 more source

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension

open access: yesAnnals of Clinical and Translational Neurology, 2020
Objective The efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits.
Jung‐Ick Byun   +13 more
doaj   +1 more source

Efficacy of Pharmacologic Treatment for Orthostatic Hypotension in the Elderly Population [PDF]

open access: yes, 2021
The purpose of this literature review is to determine the efficacy and safety of pharmacologic treatments for orthostatic hypotension (OH), with an emphasis on researching the elderly population.
Moeller, Abigail
core   +2 more sources

Home - About - Disclaimer - Privacy